Checkpoint inhibitor-induced gastritis followed by delayed severe hepatitis in a patient with lung metastases of head and neck squamous cell carcinoma: a case report

Pembrolizumab, an anti-programmed death-1 (PD-1) receptor monoclonal antibody, is an effective first-line therapy for metastatic head and neck squamous cell carcinoma. Immune-related adverse events (irAEs) are well-described complications of PD-1 inhibitors, and multiorgan irAEs are known to occur o...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Tomoyuki, Hashii, Yoshiko, Murayama, Sei, Ishizuka, Yasunobu, Kojitani, Yoshiki, Nishio, Minako, Kudo, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213227/
https://www.ncbi.nlm.nih.gov/pubmed/37251947
http://dx.doi.org/10.3389/fonc.2023.1164236

Ejemplares similares

Ejemplares similares